Notifications
Clear all
Topic starter
02/09/2021 3:41 pm
The global oncolytic virus therapy market size is expected to reach USD 866.1 Million at a steady CAGR of 23.9% in 2028, according to latest analysis by Emergen Research. Steady growth of oncolytic virus therapy market can be attributed to rising cancer incidence globally. The report provides detailed insights into Oncolytic Virus Therapy market revenue trends, industry trends, consumer trends, market size, market share, market revenue growth drivers, and forecast, along with ranging impact of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in Oncolytic Virus Therapy market size over the forecast period, 2020–2028. Global Oncolytic Virus Therapy market revenue growth is primarily driven by rising focus by major companies on product portfolio expansion, entry into new and untapped domestic and international markets, rising investments my top Oncolytic Virus Therapy market players, manufacturers, and vendors in strategic agreements and contracts, and rapidly increasing competition in the Oncolytic Virus Therapy market.
Download FREE Sample PDF Copy (Customized Sample PDF File delivered as per your specific requirement)
The report includes profiles of major Oncolytic Virus Therapy players in the market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials. Also included are details regarding top Oncolytic Virus Therapy market players, manufacturers, and vendors and the various strategies being deployed in the market and objectives for these strategies. In addition, rapidly rising demand and deployment in respective sectors/industries in major and developing countries is supporting growth in terms of Oncolytic Virus Therapy market share contribution of these countries. In addition, Oncolytic Virus Therapy market share contribution is expected to continue to incline steadily over the forecast period due to favorable government policies, advancements in technology, and steady economic growth across various regions and countries.
Access the Entire Report packed with TOC, Tables and Figures and Outline of Prominent Companies
Some Key Highlights in the Report
- In October 2020, Oncolytics Biotech made announced the signing of a partnership agreement with AIO and Roche to commence a Phase ½ trial(GOBLET) for gastrointestinal cancer. The trial would examine the use of pelareorep with anti-PD-L1 checkpoint inhibitor by Roche in cancer patients.
- Monoclonal antibodies are considered beneficial in stimulating immune responses to destroy cancer cells. In addition, certain monoclonal antibodies are capable of blocking the connection between the cellular growth promoting proteins and cancer cells, thereby killing the cancer cells.
- Oncolytic virus therapy in the treatment of lung cancer is used to deliver specific immunomodulatory or therapeutic genes to destroy cancer cells. Oncolytic virus therapy holds significant potential to improve tumor cell oncolysis and circumvent resistance mechanisms of tumor cells. It was estimated that in 2020, over 0.2 million adults in the US were diagnosed with lung cancer, which accounted for around 13.0% of the total individuals diagnosed with cancer in the same year.
Region wise performance of the Oncolytic Virus Therapy industry
North America Oncolytic Virus Therapy market revenue growth was relatively higher than that of other regional markets in 2020. North America Oncolytic Virus Therapy market revenue is expected to continue to remain dominant over the forecast period, supported by robust presence of top market players, manufacturers, and vendors, and favorable government policies and norms in countries in the region.
Asia Pacific Oncolytic Virus Therapy market revenue registered fastest growth rate in 2020, and this trend is expected to continue over the forecast period. Asia Pacific Oncolytic Virus Therapy market revenue growth is driven by significant market revenue contribution from China, India, and South Korea. China is a robust hub for top Oncolytic Virus Therapy market players, manufacturers, and vendors, as well as easy access to raw materials and workforce at more economical costs that that of other regional markets.
Europe Oncolytic Virus Therapy market revenue is expected to continue to remain steady over the forecast period, attributed to changing trends in various market and robust focus on research and development initiatives by top market players, manufacturers, and vendors to expand global footprint and drive revenues and profits.
We can customize our reports for our customers, for instance, we can add or remove manufacturers, applications or product types, whatever you need in the report. Ask for it by contacting us
The research provides answers to the following key questions:
- What will be the growth rate and the market size of the Oncolytic Virus Therapy industry for the forecast period 2020-2027?
- What are the major driving forces expected to impact the development of the Oncolytic Virus Therapy market across different regions?
- Who are the major driving forces expected to decide the fate of the Oncolytic Virus Therapy industry worldwide?
- Who are the prominent market players making a mark in the Oncolytic Virus Therapy market with their winning strategies?
- Which Oncolytic Virus Therapy industry trends are likely to shape the future of the industry during the forecast period 2020-2027?
- What are the key barriers and threats believed to hinder the development of the industry?
- What are the future opportunities in the Oncolytic Virus Therapy market?
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:
- United States
- Europe
- China
- Japan
- Southeast Asia
- India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa
Avail Discount on Oncolytic Virus Therapy Market Report
Why Choose Emergen Research?
- Strong Industry Focus
- Extensive Product Offerings
- Customer Research Services
- Robust Research Methodology
- Comprehensive Reports
- Latest Technological Developments
- Value Chain Analysis
- Potential Market Opportunities
- Growth Dynamics
- Quality Assurance
- Post-sales Support
This topic was modified 3 years ago by Amandeep Bansal
